Ligueros-Saylan, Monica,Matchaba, Patrice,Thuren, Tom,Ridker, Paul,Libby, Peter,Ottewell, Penelope,Lau, Yi Yang,Dugan, Margaret
申请号：
AU2018287519
公开号：
AU2018287519A1
申请日:
2018.05.03
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.
